Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1606 of 6351
-
New hope for arthritis sufferers: experimental drugs enter human trials
Disease control Recruiting nowRheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheum…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a pill boost brain recovery after stroke? new trial begins
Disease control OngoingThe purpose of this interventional study is to determine whether neflamapimod can improve residual physical disability and/or cognitive dysfunction after Moderate to Severe Acute Ischaemic Stroke.
Phase 2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New chemo combo strategy aims to outsmart pancreatic cancer
Disease control Recruiting nowA prospective, interventional, single-center, single-arm, open-label, phase II study for patients with metastatic pancreatic cancer. The intervention consists of monthly alternating standard chemotherapy regimens-NALIRIFOX and GnP. The hypothesis is that induction therapy with al…
Phase 2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a simple test predict CAR t success? new study hopes to find out
Knowledge-focused Recruiting nowThe INTeRCePT 2 study aims to develop a predictive assay to determine which patients with B cell lymphoma are most likely to respond to CAR T cell therapy. This assay combines five components for longitudinal profiling of each patient. The goal of the trial is that the assay can …
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Brain zaps may restore speech and hand movement in stroke survivors
Knowledge-focused Recruiting nowThe goal of this study is to verify whether the use of deep brain stimulation can improve motor function of the hand and arm and speech abilities for people following a stroke. Participants will undergo a surgical procedure to implant deep brain stimulation electrode leads. The e…
Sponsor: Jorge Gonzalez-Martinez • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a Music-Based app keep boosting reading skills months later?
Knowledge-focused CompletedPoppins-02-b is an observational follow-up study examining the medium-term effect on non-inferiority of the previous training with the digital medical device (DMN) Poppins Clinical for cognitive and musical training in addition to bi-monthly speech and reading therapy sessions on…
Sponsor: Poppins • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can a fake vagus nerve device fool the Body's inflammation response?
Knowledge-focused Recruiting nowTranscutaneous auricular vagus nerve stimulation (taVNS) has become a therapy of interest for treating chronic immune-medicated illnesses in adults and children. Vagustim™ taVNS devices are commercially available devices that have been used in clinical and non-clinical studies ex…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
10-Year study tracks stent graft safety in 1,500 aortic patients
Disease control Recruiting nowAn observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical pr…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a simple roadside test catch liver disease before it turns deadly?
Knowledge-focused Recruiting nowRegardless of its etiology (chronic hepatitis B or C, alcohol consumption, metabolic steatohepatitis, hemochromatosis, autoimmune liver disease), cirrhosis is a real public health issue. Cirrhosis is a chronic disease and can get complicated by liver cancer, digestive hemorrhage,…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New robotic suit aims to get spinal injury patients walking again at home
Symptom relief Recruiting nowThe goal of this clinical trial is to to confirm the safety and performance of the ABLE Daily to perform ambulatory functions in home and community settings for people with spinal cord injury. The experimental period will cover the training period with the ABLE Daily exoskeleton…
Sponsor: ABLE Human Motion S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New depression drug SPT-300 enters Mid-Stage trial
Symptom relief Recruiting nowThis is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Phase 2 • Sponsor: Seaport Therapeutics • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New patch pump aims to simplify diabetes management
Disease control Recruiting nowThe Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW…
Sponsor: Charles University, Czech Republic • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New pill could help heart failure patients walk farther and feel better
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (HF).
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Strong man program aims to curb substance use in native men
Disease control Recruiting nowThe Hastiin Bidziil (Strong man) Intervention study is part of a larger project called, Community-Driven Indigenous Research, Cultural Strengths \& Leadership to Advance Equity in Substance Use Outcomes (CIRCLE) Center of Excellence. CIRCLE aims to address drug use related health…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a diabetes drug help teens lose weight? new study investigates
Disease control Recruiting nowThe Joule MARS study is a single center, randomized, open label clinical trial aiming to explore the metabolic adaptations that occur in response to weight management in adolescents with obesity. Behavioural lifestyle intervention with and without a pharmacological intervention -…
Phase 4 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for blood cancer patients: STP938 trial targets tough cases
Disease control Recruiting nowThe goal of this clinical trial is to learn if the drug STP938 works to treat adults with high risk essential thrombocythaemia (ET) who are resistant to, or intolerant of, hydroxycarbamide (also known as hydroxyurea) therapy. The trial will also learn about the safety of STP938. …
Phase 2 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Breathe easier: study tests if renovating homes and purifying indoor air can transform lung health
Disease control Recruiting nowThis project will compare the health effects of public housing renovation, neighborhood built and social environment improvements, and indoor air purification, alone and in combination, as well as the cost effectiveness of each approach. STUDY 1: The study will assess the effect…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New vaccine booster aims to shield against many coronaviruses
Vaccine OngoingThe clinical trial is a phase1/2a, open-label, dose-escalating, multicentre trial evaluating the safety and immunogenicity of the CD40.Pan.CoV vaccine, adjuvanted or not, as a booster injection in adult participants in France. 48 participants divided into 4 cohorts will be includ…
Phase 1/2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
New vaccine aims to shield against 24 pneumonia strains
Vaccine CompletedA Phase Ib/II clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24)developed by Sinovac Life Science Co., Ltd will be conducted in adults aged ≥18 years. The objective of the study is to evaluate the safety and immunogenicity of Sinovac PCV24. The trial is a randomi…
Phase 1/2 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
New hope for head and neck cancer: drug combo shows promise after standard treatment fails
Disease control Recruiting nowSquamous cell carcinoma of the head and neck (SCCHN) arises from epithelial cells and occurs in the oral cavity, pharynx and larynx. SCCHN is the seventh most common cancer worldwide with an annual incidence of approximately 90.000 cases per year in Europe. Recurrent / metastati…
Phase 2 • Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC